Unique ID issued by UMIN | UMIN000032497 |
---|---|
Receipt number | R000037057 |
Scientific Title | The risk of pneumonia and hospitalization in patients with chronic abstructive pulmonary disease |
Date of disclosure of the study information | 2018/05/08 |
Last modified on | 2020/05/08 11:35:39 |
The risk of pneumonia and hospitalization in patients with chronic abstructive pulmonary disease
The risk of pneumonia and hospitalization in patients with COPD
The risk of pneumonia and hospitalization in patients with chronic abstructive pulmonary disease
The risk of pneumonia and hospitalization in patients with COPD
Japan |
chronic abstructive pulmonary disease
Pneumology |
Others
NO
We will research on COPD pneumonia and hospitalized patients from the viewpoint of cough symptoms and cough sensitivity to identify risk factors, leading to the establishment of future preventive measures.
Others
We will examine whether the results of the previous report can be reproduced on the frequency of exacerbations of COPD or whether hospitalization due to exacerbation is related to cough sensitivity.
Exploratory
Pragmatic
Not applicable
Evaluate the history of pneumonia and the history of hospitalization related to COPD from patients with COPD in relation to cough sensitivity
Clinical indicators other than cough sensitivity related to pneumonia, exacerbation, hospitalization in patients with COPD (presence or absence of asthma complication, cardiac function, spinal column standing muscle volume, serum IgE, BNP, etc.)
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1)COPD patients (including cases of asthma combined) who were consulted or hospitalized at respiratory department of the hospital from January 2018 to March 2021
2)Patients who have written consent from the patient himself about participation in this study
1)Patients with less frequent hospital visits which are difficult to follow progress
2)Patients with complications of other obvious respiratory diseases such as interstitial lung disease
3)Minor
4)Patients who are judged inappropriate as the subject by the research director
100
1st name | Yoshihiro |
Middle name | |
Last name | Kanemitsu |
Nagoya City University School of Medical Sciences
Department of Respiratory Medicine, Allergy and Clinical Immunology
4678601
1, Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, Japan
052-853-8216
m-take19@med.nagoya-cu.ac.jp
1st name | Masaya |
Middle name | |
Last name | Takemura |
Nagoya City University School of Medical Sciences
Department of Respiratory Medicine, Allergy and Clinical Immunology
4678601
1, Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, Japan
052-853-8216
m-take19@med.nagoya-cu.ac.jp
Nagoya City University School of Medical Sciences
Department of Respiratory Medicine, Allergy and Clinical Immunology
Nagoya City University School of Medical Sciences
Department of Respiratory Medicine, Allergy and Clinical Immunology
Self funding
Shizuoka general hospital
Nagoya City University Hospital Clinical Trial Management Center
1, Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, Japan
052-858-7215
clinical_research@med.nagoya-cu.ac.jp
NO
2018 | Year | 05 | Month | 08 | Day |
Unpublished
Open public recruiting
2018 | Year | 04 | Month | 26 | Day |
2018 | Year | 04 | Month | 26 | Day |
2018 | Year | 05 | Month | 09 | Day |
2021 | Year | 03 | Month | 31 | Day |
April 26, 2018 Approval of in-campus ethics review
2018 | Year | 05 | Month | 07 | Day |
2020 | Year | 05 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037057